Role of Methyl Prednisolone in Longitudinal Extensive Transverse Myelitis (LETM) in Children

Area of Science:

• Pediatric Neurology
• Clinical Efficacy Studies
• Developing Country Health Research

Background:

• Longitudinal extensive transverse myelitis (LETM) in children presents a significant neurological challenge, particularly in developing nations.
• The therapeutic role of methylprednisolone in pediatric LETM remains underexplored in contexts like Pakistan.
• This study addresses a critical knowledge gap regarding corticosteroid efficacy in a vulnerable pediatric population.

Purpose of the Study:

• To evaluate the efficacy of methylprednisolone in treating children diagnosed with longitudinal extensive transverse myelitis.
• To establish baseline data on methylprednisolone treatment outcomes for pediatric LETM in Pakistan.
• To provide evidence supporting early intervention strategies for LETM in resource-limited settings.

Main Methods:

• A quasi-experimental, hospital-based, descriptive prospective study was conducted over one year.
• Thirty-four pediatric patients with LETM were enrolled from a tertiary care children's hospital.
• Patients received intravenous methylprednisolone (30mg/kg/day, max 1g) for five consecutive days, with pre- and post-treatment assessments.

Main Results:

• Complete recovery was observed in 41.2% of the pediatric patients.
• Partial recovery was noted in 58.8% of the participants.
• Statistical analysis revealed significant correlations between treatment response and factors including gender, spinal cord lesion area, muscle power, and autonomic dysfunction (p<0.05).

Conclusions:

• Early administration of methylprednisolone in pediatric LETM is beneficial.
• Prompt treatment can significantly reduce the morbidity associated with LETM in children.
• This study supports the use of methylprednisolone as a key therapeutic agent for pediatric LETM in Pakistan.